IPA preparing for a long journey. Wait for confirmation.
ImmunoPrecise's PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays IPA publishes its scientific paper "Cornering an Ever-Evolving Coronavirus: TATX-03, a Fully Human, Synergistic, Multi-Antibody Cocktail Targeting the SARS-CoV-2 Spike Protein with in vivo Efficacy" on bioRxiv VICTORIA, British...
IPA is the latest retail banger this week after NURO and CEMI took center stage during the first half. I took out the fibs back to the previous lows and plotted against the ATH. Interesting levels formed which showed pivot support/resistance at the 786 fib line and the 618 maintaining a secondary level of importance. After failing to break and hold above it,...
Good news and even better volume today. We should see this build a base around $10 - $12. Earnings on the 29th should be interesting. VWAP rejected and momentum slowed down. Long $IPA. There is no way big pharma doesn't like this play.
Pupm&Dump trading strategy idea. $IPA is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $7,88; stop-loss — $9,01; take-profit — $5,62. Do not view this idea as a recommendation for trading or investing. It is...